Aster DM Quality Care (NSE:ASTERDM) Risk Assessment


NSE:ASTERDM Aster DM Quality Care Ltd NSE:ASTERDM
77 GF Score
Price ₹808.90
GF Value ₹675.83
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Aster DM Quality Care Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Aster DM Quality Care is: Moderate Risk: Sensitive, better choose undervalued stock.

Aster DM Quality Care  (NSE:ASTERDM) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Aster DM Quality Care Risk Assessment Related Terms

NSE:ASTERDM vs HCA, THC, DVA: Risk Assessment Comparison

For the Medical Care Facilities subindustry, Aster DM Quality Care's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aster DM Quality Care Risk Assessment vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aster DM Quality Care's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Aster DM Quality Care's Risk Assessment falls into.


NSE:ASTERDM
77GF Score
Aster DM Quality Care Ltd NSE:ASTERDM
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Aster DM Quality Care (NSE:ASTERDM) Overvalued in 2026?

Based on GuruFocus' analysis, Aster DM Quality Care stock appears to be overvalued. The current stock price of ₹808.90 is trading 19.7% above its estimated GF Value™ of ₹675.83. GuruFocus considers Aster DM Quality Care to be Modestly Overvalued.

Key valuation signals for NSE:ASTERDM:

  • Risk Assessment:
  • GF Value™: ₹675.83 vs. price of ₹808.90 (19.7% above fair value)
  • GF Score™: 77/100 with 7 warning signs

No single metric tells the full story. See the NSE:ASTERDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aster DM Quality Care Business Description

Other Exchanges 540975:India
Address 27 and 27/1, Mission Road, Awfis, 2nd Floor, Renaissance Centra, Sampangirama Nagar, Bengaluru, KA, IND, 560027
Aster DM Healthcare Ltd is an India-based integrated healthcare provider. The group operates a comprehensive healthcare network comprising approximately 19 hospitals, 10 clinics, over 200 pharmacies, and more than 255 diagnostic laboratories across states. Its business segments include Hospitals, Clinics, Retail Pharmacies, and Others, with the majority of revenue derived from the Hospitals segment. Aster has been delivering high-quality care from primary to quaternary through dedicated personnel across clinical and non-clinical roles. Aster has a presence in metropolitan as well as Tier II and Tier III cities, and is committed to providing advanced and accessible healthcare in line with global standards, guided by a patient-first approach.
77GF Score

Get the complete analysis for NSE:ASTERDM

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹808.90
Price
₹675.83
GF Value